• Company

HOME Company History

History

2024

  • 01.02
  • Inaugurated Kim Woo Tae for C.E.O and Chairman

  • 01.02
  • Inaugurated BaekKwang Seok for President

2023

  • 11.09
  • Groundbreaking Ceremony for ¡°Oral Solid Dosage plant¡±
    in Hwaseong Factory.

  • 07.15
  • Recertified ¡°ISO37001 Anti-bribery management system¡±

2022

  • 07.13
  • Signing a joint development agreement for Cocrystals
    Proton Pump-Inhibitor between Guju Pharm - Unicel Lab

2020

  • 08.20
  • Certified ¡°ISO37001 Anti-bribery management system¡±

2018

  • 10.05
  • Central R&D Center Established (Suwon, Gwanggyo)

2017

  • 02.27
  • Relocated sales headquarter and improving the work environment on the 2nd floor of head office

2014

  • 01.03
  • Completed Remodeling of office and commenced outdoor advertisement on the 12th floor of head office

2013

  • 09.17
  • Completed expansion and relocation of Soft capsule,
    solid preparation (Tablet, Capsule) lines to 3rd floor of new wing in factory.

  • 07.12
  • Appointed WooTae Kim as a single representative director

  • 06.21
  • The founder of GUJU pharmaceutical, MyungSup Kim, passed away

  • 02.01
  • Had 53 products passed Bioequivalence Testing

2010

  • 09.01
  • Launched the first low-volume 40mg MPSS(Methyl Prednisolone) formulation in Korea.

2009

  • 05.30
  • Completed remodeling of automation injectable ample and
    vial (injectable powder) line in a new wing of the factory

2007

  • 06.30
  • Completed remodeling of production wing in the main building

2005

  • 01.10
  • Extended the R&D center (Recruiting doctorate researchers)

2004

  • 01.01
  • Appointed WooTae Kim as a CEO

2003

  • 10.01
  • Released No. 6 of Korea New drug "Apitoxin Inj."

  • 02.17
  • Completed enlargement of the warehouse

2002

  • 08.30
  • Extended the Quality Control department and the R&D center in Hwaseong factory

1998

  • 03.26
  • 12F River tower, 50, Beodeunaru-ro, Yeongdeungpo-gu, Seoul, Republic of Korea

1995

  • 06.29
  • Completed the second construction of Hwaseong factory

1992

  • 06.26
  • Hwaseong(Osan) Factory was formally designated as KGMP eligible facilities (solid preparation(Tablet, Capsule), Collyrium, Oral liquid, Ointment)

1988

  • 05.23
  • Relocation of the Factory : 25-4, Jegiri-san, Jeongnam-myeon, Hwaseong-si, Gyeonggi-do, Republic of Korea

  • 05.04
  • 1988. 05. 23 Relocation of the Factory

1987

  • 09.01
  • Extended the Head Office in Won-chang Building, 26-3, Yeouido-dong, Yeongdeungpo-gu, Seoul, Republic of Korea

  • 05.24
  • Groundbreaking Ceremony of Hwaseong(Osan) Factory

1985

  • 02.11
  • Selected as No.84-350 promising small and medium-sized business (Small & Medium Business Corporation)

1984

  • 06.12
  • Approved No.84-1164 project on modernization of mall and medium-sized businesses (Small & Medium Business Corporation)

  • 03.05
  • Appointed as a company for wartime mobilization in accordance with the article 84-63 of regulations on resource management by No.15 article 1 (The minister of Department of Health and Social Affairs in Korea)

1980

  • 03.14
  • secured the construction site for Hwaseong(Osan) Factory in 25-1, Jegiri-san, Jeongnam-myeon, Hwaseong-si, Gyeonggi-do, Republic of Korea

1978

  • 03.17
  • Appointed MyungSup Kim as a CEO

1974

  • 11.19
  • Founded GUJU PHARM. CO. LTD.